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Purpose: The aim of this study was to investigate the incidence and spectrum of malignant tumors in Korean neuro-
fibromatosis type 1 (NF1) patients. Methods: We retrospectively reviewed 125 patients who were diagnosed with NF1 at a 
single institution from 1995 to 2010. The incidence, location, histologic type, and radiologic findings of malignant tumors as 
well as development of multiple primary tumors were analyzed. Results: Eighteen malignant tumors occurred in 16 patients 
(12.8%) among 125 Korean NF1 patients; 9 carcinomas, 8 sarcomas and 1 central nervous system (CNS) tumor. Five tumors 
were of nervous system origin and 13 were non-nervous system tumors. The locations of the tumors were as follow: 1 CNS, 2 
lung, 3 breast, 3 stomach, 3 small bowel, 1 colon, 1 liver, 1 uterus, 1 neck, and 2 in extremities. Three malignant peripheral 
nerve sheath tumors (MPNSTs) occurred at the neck and extremity, and one in the liver. All three gastrointestinal stromal tu-
mors (GISTs) had multiple tumors in the jejunum, and one MPNST and one pheochromocytoma were accompanied in two 
GISTs. Multiple primary tumors, benign or malignant were reported in 4 patients (25.0%), synchronously or metachronously. 
Conclusion: Korean NF1 patients had a high risk of developing malignant tumors. The common malignant tumors in 
Koreans such as breast, lung and stomach cancers developed frequently in addition to the NF1-related tumors such as 
MPNST or GIST.
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INTRODUCTION
Neurofibromatosis type 1 (NF1) is one of the cancer pre-
disposing syndrome and malignant tumors developed 
four times as often in the NF1 patient group as in the gen-
eral population [1]. Gastrointestinal stromal tumor 
(GIST), somatostatinoma and breast cancer are commonly 
related to NF1, in addition to nervous system tumors such 
as malignant peripheral nerve sheath tumor (MPNST) or 
optic nerve gliomas [2]. But, the evidence underlying the 
tumorigenesis of these NF1-related tumors are inadequate 
and it is controversial which types of tumor are NF1- 
related. In particular, there are few studies in Korea. Thus, 
we performed this study to investigate the incidence and 
spectrum of malignant tumors in Korean NF1 patients.Eui Tae Kim, et al.
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Age Sex Histologic type of tumor Tumor location Multiple primary tumor Survival period (mo)
56 M Adenocarcinoma (EGC) Stomach 51 (alive)
64 M Adenocarcinoma (AGC) Stomach 79 (alive)
45 F MPNST Liver   6 
58 F Ductal adenocarcinoma Breast, Lt Leiomyosarcoma, uterus 13 
63 F Ductal adenocarcinoma Breast, Lt 14
14 M Optic nerve glioma CNS 68 
42 F Ductal adenocarcinoma Breast, Lt 72 (alive)
70 M Adenocarcinoma (EGC) Stomach 21 (alive)
36 M MPNST Shoulder, Lt 26 
30 F GIST Jejunum 73 (alive)
67 M Adenocarcinoma Rectum IMFT, rectum 27
36 M MPNST Neck 12 (alive)
73 F NSCLC (Adenocarcinoma) Lung, Lt   4
52 F GIST Jejunum MPNST, arm, Lt 32
47 F NSCLC (spindle cell carcinoma) Lung, Lt 13
60 F GIST Jejunum Pheochromocytoma, Lt 10 (alive)
NF1, neurofibromatosis type 1; EGC, early gastric cancer; AGC, advanced gastric cancer; MPNST, malignant peripheral nerve sheath tumor; 
Lt, left; CNS, central nervous system; GIST, gastrointestinal stromal tumor; IMFT, inflammatory myofibroblastic tumour; NSCLC, 
non-small-cell lung cancer.
Table 1. Malignant tumors in 16 patients with NF1
METHODS
One hundred twenty five patients were diagnosed with 
NF1 in a single institution from 1995 to 2010. We used cri-
teria for NF1 established by the National Institute of 
Health Consensus Development Conference in 1987 [3]. 
The diagnosis of NF1 was made on the basis of clinical fea-
tures requiring the presence of at least two of the following 
criteria: six of more café-au-lait macules over 5 mm in 
greatest diameter in prepubertal individuals and over 15 
mm in greatest diameter in postpubertal individuals; two 
or more neurofibromas of any type or one plexiform neu-
rofibroma; axillary or inguinal freckling; optic pathway 
glioma; two or more Lisch nodules; bony dysplasia; or a 
first-degree relative with NF1. The mean age of patients 
was 31 years (range, 0 to 88 years), and 62 patients were 
female. The medical records of patients were retro-
spectively reviewed and the incidence, location, histologic 
type, radiologic findings of malignant tumors, develop-
ment of multiple primary tumors, and survival period af-
ter diagnosis of malignant tumors were analyzed. 
RESULTS
Incidence of malignant tumors in NF1 patients
Eighteen malignant tumors developed in 16 patients 
(12.8%) among 125 Korean NF1 patients and 17 malignant 
tumors in 15 patients (16.1%) among 93 adults over 18 
years old. The mean age of the patients at the time of diag-
nosis of malignant tumors was 51 years (range, 14 to 73 
years), and nine patients were female.
Histologic type and location of malignant tumors
The types of malignant tumors were as follows: 9 carci-
nomas, 8 sarcomas, and 1 central nervous system (CNS) 
tumor. Five tumors were nervous system origin and 13 
were non-nervous system tumor. The locations of tumors 
were as follow: 1 CNS, 2 lung, 3 breast, 3 stomach, 3 small 
bowel, 1 colon, 1 liver, 1 uterus, 1 neck, and 2 in the ex-
tremities (Table 1). Three MPNSTs developed at the neck 
and extremity and one in the liver (Fig. 1). All three GISTs 
had multiple tumors in the jejunum (Fig. 2), and 1 MPNST 
and 1 pheochromocytoma were accompanied in 2 GISTs 
(Fig. 3). Oncologic manifestations of neurofibromatosis type 1 in Korea
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Fig. 1. Radiologic appearance of malignant peripheral nerve sheath tumors in different locations. (A) Neck magnetic resonance imaging 
shows a 7.5 × 5.2 × 3.2 cm sized, heterogeneously high signal mass at right carotid space on T2 weighted image. (B) Pelvic computed 
tomography (CT) scan shows huge, enhancing mass at left buttock with bony erosion of sacrum, coccyx, and ilium. (C) Abdominal CT scan 
shows bulky, enhancing mass at right posterior segment of liver.
Fig. 2. Radiologic and gross appearance of small bowel gastrointestinal stromal tumor. (A) Abdominal computed tomography scan shows 
large, jejunal mass with several smaller masses. (B) Resected segment of jejunum shows main tumor and numerous small nodular masses 
(Reprinted from Namgung H. J Korean Surg Soc 2011;81:276-80, with permission of the Korean Surgical Society).
Multiple primary tumors
Multiple primary tumors, benign or malignant, were re-
ported in 4 patients (25.0%), synchronously or metach-
ronously.
Survival period of patients
The survival periods of patients after diagnosis of ma-
lignant tumors were less than 3 years in 8 patients (50%) 
and 5 patients already had metastasis at the time of diag-
nosis of malignant tumors.
DISCUSSION
NF1, also known as von Recklinghausen disease, is an 
autosomal dominant disorder that results from germ-line 
mutations in the NF1 gene located at chromosome 17q11.2 
[4]. NF1 reduce the average life expectancy by 10 to 15 
years and malignant tumors are the most common cause 
of death. Malignant tumors occur in 3 to 15% of NF1 pa-
tients and the high incidence of neoplasms is related with 
mutation of the NF1 gene. Neurofibromin, the protein en-
coded by the NF1  gene, is a negative regulator of the 
Ras-MAPK pathway which functions as a GTPase-activating Eui Tae Kim, et al.
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Fig. 3. Radiologic appearance of 
pheochromocytoma. Abdominal 
computed tomography scan shows 
large, well-defined, heterogeneou-
sly enhancing mass at right retro-
peritoneum. (A) Axial view. (B) 
Coronal view.
Tumor location (n) Histologic type of tumor (n) Sub-location of tumor (n) Number
CNS (8) Optic nerve glioma (3) 3
Astrocytoma (2) Cerebellum (1), spinal cord (1) 2
Meningioma (1) 1
Glioblastoma multiforme (2) 2
PNS (30) MPNST 30
Eye (1) Malignant melanoma Choroid 1
Breast (7) Ductal adenocarcinoma 7
Lung (5) Squamous cell carcinoma (1) 1
Adenocarcinoma (2) 2
Large cell carcinoma (1) 1
Spindle cell carcinoma (1) 1
Stomach (5) Adenocarcinoma (4) 4
Malignant lymphoma (1) 1
Small bowel (25) Adenocarcinoma (5) Duodenum (4), ileum (1) 5
GIST (17) Jejunum 17
Somatostatinoma (2) Ampulla of Vater 2
Leiomyosarcoma (1) Ileum 1
Colon (3) Adenocarcinoma 3
Anus (1) Malignant melanoma 1
Liver (2) Cholangiocarcinoma (1) 1
MPNST (1) 1
Gall bladder (2) Adenocarcinoma (1) 1
Squamous cell carcinoma (1) 1
Pancreas (1) Adenocarcinoma 1
Uterus (1) Leiomyosarcoma 1
Skin (1) Malignant melanoma Left hand 1
Soft tissue (2) MFH (1) Abdominal wall  1
Embryonal rhabdomyosarcoma (1) Posterior mediastinum  1
Lymphatic/hematopoietic system (4) CML (3) 3
Malignant lymphoma (1) Lymph node, pelvis 1
Total 98
CNS, central nervous system; PNS, peripheral nervous system; MPNST, malignant peripheral nerve sheath tumor; GIST, gastrointestinal 
stromal tumor; MFH, malignant fibrous histiocytoma; CML, chronic myelogenous leukemia.
Table 2. Types of malignant tumors in Korean NF 1 patientsOncologic manifestations of neurofibromatosis type 1 in Korea
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protein for Ras by catalyzing the hydrolysis of active 
Ras-GTP to an inactive Ras-GDP, and NF1 gene is thus con-
sidered as a tumor suppressor gene. Additional somatic 
inactivation of the wild type NF1 allele results in complete 
loss of functional neurofibromin activity, and cell pro-
liferation and differentiation are activated [5]. 
 The spectrum of NF1 related tumors shows selective 
patterns. MPNST and CNS tumors, such as optic nerve 
glioma or astrocytoma, are the most common NF1 asso-
ciated tumors. GIST, rhabdomyosarcoma, somatostatino-
ma, breast cancer and pheochromocytoma are also known 
as common tumors in NF1 patients. Some types of 
NF1-related tumors show different clinic-pathologic fea-
tures from those of sporadic cases. Most NF1-related 
GISTs have multiple tumors in small intestine, and muta-
tions of KIT or PDGFRA are rare [6]. Multiple primary tu-
mors, synchronous or metachronous, are more common in 
NF1 patients with cancer, thus careful staging and post-
operative surveillance is needed [7]. However, the estima-
tion of the frequencies of specific tumors in NF1 patients is 
difficult and the incidence might be overestimated be-
cause most cohort studies are based on hospital data. 
Although malignant tumors are an important cause of 
mortality in NF1, studies for NF1-related tumors are in-
adequate and the mechanism underlying tumorigenesis 
remains obscure. Therefore, a large cohort study is needed 
to investigate the incidence and spectrum of NF1-related 
tumors, in addition to genetic study for finding out of un-
derlying patho-mechanism.
We have searched journals from the web site “http:// 
koreamed.org” using keywords “neurofibromatosis” and 
“von Recklinghausen disease” to investigate the pattern of 
malignant tumors in Korean NF1 patients. Three hundred 
twelve articles were founded from 1972 to 2011 and 82 cas-
es of NF1 patients with malignant tumors were reported 
from 64 studies (Table 2). MPNSTs are the most frequent 
malignant tumors associated with NF1 and the lifetime 
risk of MPNST in NF1 patients is 8 to 13%. NF1 associated 
MPNSTs tend to occur at a younger age than those without 
the syndrome, often metastasize in an early phase of the 
disease and have a poor prognosis. Thirty one MPNSTs in-
cluding four cases of this study were reported from 21 ar-
ticles [8-10]. The distribution of MPNSTs shows similar 
patterns with other studies: 5 head and neck, 9 trunk 
(including 2 cases of breast), 6 extremities, 3 intra-thoracic, 
2 intra-abdominal, 5 retro-peritoneum, and 1 spine. The 
lifetime risk of GISTs is 6% for NF1 patients, and the 
NF1-related GISTs show different clinic-pathologic char-
acteristics from those of sporadic one. Seventeen GISTs in-
cluding 3 cases in this study were reported from 10 articles 
[11-13]. Fourteen (82%) developed in female patients and 
all occurred in the jejunum multiply. All GISTs were pos-
itive to CD117 and 8 from 9 tumors had wild type KIT and 
PDGFRA. In children with NF1, the most common neo-
plasm apart from neurofibroma, is CNS tumors such as 
optic nerve glioma, and CNS tumors occur in approx-
imately 15% of children with NF1. Eight CNS tumors in-
cluding one from this study were reported from 6 articles 
[14]. Pheochromocytoma is a rare tumor of the adrenal 
gland that affects about 1% of NF1 patients and 8 pheo-
chromocytomas were reported from 6 articles [15,16]. Ten 
multiple primary tumors (12.2%), benign or malignant, 
were found in 82 NF1 patients. 
In this study, 18 malignant tumors developed in 16 pa-
tients (12.8%) among 125 Korean NF1 patients and we 
could confirm that Korean NF1 patients also had a high 
risk of developing malignant tumors. The types of tumors 
were similar with other studies. Uncommon tumors in 
Korean such as MPNST, GIST, and CNS tumors are prob-
ably NF1-related tumors. But, we cannot exclude the 
chance concomitance of two diseases for common tumors 
such as stomach, lung and colon cancer [17-20]. In NF1 pa-
tients, late diagnosis of malignant tumors with metastasis 
is common, and patients tend to refuse active treatment 
due to the economic reason and multiple primary tumors 
frequently develop. So, malignant tumors in NF1 patients 
usually have poor prognosis. This study has selection bias 
and the limitation in estimating the incidence of malignant 
tumors because this study was based on hospital data. But, 
this study might help in estimating the spectrum of malig-
nant tumors in Korean NF1 patients.
In conclusion, Korean NF1 patients had a high risk of 
developing malignant tumors. The common malignant tu-
mors in Koreans such as breast, lung, and colon cancer de-
veloped frequently in addition to the NF1-related tumors 
such as MPNST or GIST. But, a large population based co-Eui Tae Kim, et al.
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hort study is needed to confirm the incidence and spec-
trum of malignant tumors in Korean NF1 patients, be-
cause there are relatively few numbers of malignant tu-
mors in NF1 patients in a single institution.
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